Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Dabur India says US FDA issues import alert for Silvassa plant drugs
Dabur India said the United States Food and Drug Administration (USFDA) issued Import Alert 66-40 for drugs made at part of its Silvassa facility after an inspection flagged data integrity and maintenance deficiencies.
Why US drug regulator has taken action against drugs imported from Dabur India
A live bird and bird droppings were found in the raw material warehouse, about 30 feet from packaging materials.
Dabur shares in focus after USFDA issues import alert for drugs made at Silvassa plant. Check details
Dabur India share price was trading on a flat note with a positive bias. The stock opened at ₹422.15 as against ₹422.20 apiece. It hit the day's high and low of ₹428.80 and ₹420.45.
Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s why
Dabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data integrity lapses. The company said the impact is limited to a small portion of operations, while broader business and domestic sales remain unaffected.
Dabur India shares in focus as US FDA issues import alert for Silvassa manufacturing plant - Upstox
Dabur India shares in focus as US FDA issues import alert for Silvassa manufacturing plantUpstox
Stocks to Watch today: Vedanta, Cipla, Dabur, Vi, Oil India, CDSL and more
Stocks to watch today: Vedanta, Cipla, Dabur, Vi, Oil India, CDSL, Ratnaveer Precision, NLC India, Sagility among others will in focus today.
Dabur shares in focus after US FDA places Silvassa plant products under import alert
Dabur said the US FDA issued the import alert on June 10, 2026, following its review of the company's responses and the Establishment Inspection Report (EIR) related to an earlier inspection of the plant located in Silvassa, Dadra and Nagar Haveli.
Stocks To Watch Today: Vedanta, Dabur, Cyient, Tata Capital, Federal Bank & More
Here's a look at stocks that are likely to be in focus during the trading session on Thursday.
US drug regulator issues import alert for drugs made at a Dabur India plant
The US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed significant issues with data integrity and factory maintenance. Critical manufacturing records were reportedly falsified. Live birds and droppings were also found in a raw material warehouse.
Dabur India flags US FDA import alert on certain drug products from Silvassa plant
Shares of Dabur India Ltd ended at ₹422.20, down by ₹5.65, or 1.32%, on the BSE.
FMCG shares in focus; HUL, Dabur, Nestle, Marico gain up to 3%; here's why
Despite global uncertainties, subpar monsoon outlook and volatile commodity prices, FMCG firms have given resilient outlook for FY27 with H2FY27 expected to be better versus H1FY27, say analysts.
Nifty FMCG index sheds 2%; Dabur slips 4%; ITC, Britannia hit 52-week lows
In the past one month, the FMCG index has underperformed the market, by falling 5 per cent, as against 2.3 per cent decline in Nifty 50.